 Item 3:
Quantitative and Qualitative Disclosures about Market Risks
For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Part 2 Item 7a, “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form
10-K filed with the SEC on March 1, 2019.
There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form
10-K for the fiscal year ended December 31, 2018.
In addition to market risks described in our Annual Report on Form
